18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

ECOG 0 4 25 29 B-clinical_variable
performance 5 16 30 41 I-clinical_variable
status 17 23 42 48 I-clinical_variable
of 24 26 49 51 O
0 27 28 52 53 B-lower_bound
- 28 29 53 54 O
1 29 30 54 55 B-upper_bound

Medical 0 7 56 63 O
suitability 8 19 64 75 O
for 20 23 76 79 O
resection 24 33 80 89 B-treatment
, 33 34 89 90 O
including 35 44 91 100 O
documented 45 55 101 111 O
medical 56 63 112 119 O
and 64 67 120 123 O
cardiac 68 75 124 131 O
clearance 76 85 132 141 O

Patients 0 8 142 150 O
must 9 13 151 155 O
sign 14 18 156 160 O
a 19 20 161 162 O
document 21 29 163 171 O
that 30 34 172 176 O
indicates 35 44 177 186 O
that 45 49 187 191 O
they 50 54 192 196 O
are 55 58 197 200 O
aware 59 64 201 206 O
of 65 67 207 209 O
the 68 71 210 213 O
investigative 72 85 214 227 O
nature 86 92 228 234 O
of 93 95 235 237 O
the 96 99 238 241 O
treatment 100 109 242 251 B-treatment
of 110 112 252 254 O
this 113 117 255 259 O
protocol 118 126 260 268 O
, 126 127 268 269 O
and 128 131 270 273 O
the 132 135 274 277 O
potential 136 145 278 287 O
benefits 146 154 288 296 O
and 155 158 297 300 O
risks 159 164 301 306 O

Patients 0 8 307 315 O
that 9 13 316 320 O
have 14 18 321 325 O
been 19 23 326 330 O
treated 24 31 331 338 O
with 32 36 339 343 O
prior 37 42 344 349 O
Mantle 43 49 350 356 O
field 50 55 357 362 O
radiation 56 65 363 372 B-treatment

Patients 0 8 373 381 O
unwilling 9 18 382 391 O
or 19 21 392 394 O
unable 22 28 395 401 O
due 29 32 402 405 O
to 33 35 406 408 O
cognitive 36 45 409 418 B-chronic_disease
impairment 46 56 419 429 I-chronic_disease
to 57 59 430 432 O
sign 60 64 433 437 O
informed 65 73 438 446 O
consent 74 81 447 454 O

Patients 0 8 455 463 O
who 9 12 464 467 O
have 13 17 468 472 O
a 18 19 473 474 O
history 20 27 475 482 O
of 28 30 483 485 O
HIV 31 34 486 489 B-chronic_disease
disease 35 42 490 497 I-chronic_disease

Patients 0 8 498 506 O
who 9 12 507 510 O
have 13 17 511 515 O
a 18 19 516 517 O
white 20 25 518 523 B-clinical_variable
count 26 31 524 529 I-clinical_variable
less 32 36 530 534 O
than 37 41 535 539 O
2,500 42 47 540 545 B-upper_bound
per 48 51 546 549 I-upper_bound
cubic 52 57 550 555 I-upper_bound
mm 58 60 556 558 I-upper_bound
or 61 63 559 561 O
platelets 64 73 562 571 B-clinical_variable
less 74 78 572 576 O
than 79 83 577 581 O
100,000 84 91 582 589 B-upper_bound
/ 91 92 589 590 I-upper_bound
cubic 92 97 590 595 I-upper_bound
mm 98 100 596 598 I-upper_bound

Patients 0 8 599 607 O
who 9 12 608 611 O
have 13 17 612 616 O
been 18 22 617 621 O
treated 23 30 622 629 O
with 31 35 630 634 O
pemetrexed 36 46 635 645 B-treatment
if 47 49 646 648 O
the 50 53 649 652 O
last 54 58 653 657 O
dose 59 63 658 662 O
of 64 66 663 665 O
pemetrexed 67 77 666 676 O
is 78 80 677 679 O
< 81 82 680 681 O
30 83 85 682 684 B-upper_bound
days 86 90 685 689 I-upper_bound
to 91 93 690 692 O
the 94 97 693 696 O
date 98 102 697 701 O
of 103 105 702 704 O
surgery 106 113 705 712 B-treatment

Patients 0 8 713 721 O
who 9 12 722 725 O
have 13 17 726 730 O
received 18 26 731 739 O
prior 27 32 740 745 B-treatment
surgery 33 40 746 753 I-treatment
, 40 41 753 754 O
gene 42 46 755 759 B-treatment
therapy 47 54 760 767 I-treatment
, 54 55 767 768 O
or 56 58 769 771 O
combination 59 70 772 783 B-treatment
chemotherapy 71 83 784 796 I-treatment
will 84 88 797 801 O
be 89 91 802 804 O
permitted 92 101 805 814 O
if 102 104 815 817 O
it 105 107 818 820 O
has 108 111 821 824 O
been 112 116 825 829 O
at 117 119 830 832 O
least 120 125 833 838 O
30 126 128 839 841 B-lower_bound
days 129 133 842 846 I-lower_bound
since 134 139 847 852 O
the 140 143 853 856 O
last 144 148 857 861 O
treatment 149 158 862 871 B-treatment

Patients 0 8 872 880 O
who 9 12 881 884 O
have 13 17 885 889 O
severe 18 24 890 896 O
liver 25 30 897 902 B-chronic_disease
disease 31 38 903 910 I-chronic_disease
including 39 48 911 920 O
cirrhosis 49 58 921 930 B-chronic_disease
, 58 59 930 931 O
Grade 60 65 932 937 B-lower_bound
III 66 69 938 941 I-lower_bound
- 69 70 941 942 O
IV 70 72 942 944 B-upper_bound
elevations 73 83 945 955 O
in 84 86 956 958 O
liver 87 92 959 964 O
function 93 101 965 973 O
studies 102 109 974 981 O
, 109 110 981 982 O
or 111 113 983 985 O
bilirubin 114 123 986 995 O
in 124 126 996 998 O
excess 127 133 999 1005 O
of 134 136 1006 1008 O
1.5 137 140 1009 1012 O
mg 141 143 1013 1015 O
/ 143 144 1015 1016 O
deciliter 144 153 1016 1025 O

Patients 0 8 1026 1034 O
with 9 13 1035 1039 O
a 14 15 1040 1041 O
histologic 16 26 1042 1052 O
diagnosis 27 36 1053 1062 O
of 37 39 1063 1065 O
MPM 40 43 1066 1069 B-cancer
, 43 44 1069 1070 O
epithelioid 45 56 1071 1082 O
subtype 57 64 1083 1090 O
, 64 65 1090 1091 O
who 66 69 1092 1095 O
in 70 72 1096 1098 O
the 73 76 1099 1102 O
opinion 77 84 1103 1110 O
of 85 87 1111 1113 O
the 88 91 1114 1117 O
attending 92 101 1118 1127 O
thoracic 102 110 1128 1136 O
surgeon 111 118 1137 1144 O
can 119 122 1145 1148 O
receive 123 130 1149 1156 O
a 131 132 1157 1158 O
macroscopically 133 148 1159 1174 O
complete 149 157 1175 1183 O
resection 158 167 1184 1193 O
of 168 170 1194 1196 O
tumor 171 176 1197 1202 B-cancer

Patients 0 8 1203 1211 O
with 9 13 1212 1216 O
active 14 20 1217 1223 O
invasive 21 29 1224 1232 B-cancer
cancers 30 37 1233 1240 I-cancer
, 37 38 1240 1241 O
other 39 44 1242 1247 O
than 45 49 1248 1252 O
MPM 50 53 1253 1256 B-cancer
, 53 54 1256 1257 O
that 55 59 1258 1262 O
require 60 67 1263 1270 O
additional 68 78 1271 1281 O
treatment 79 88 1282 1291 B-treatment
, 88 89 1291 1292 O
except 90 96 1293 1299 O
non 97 100 1300 1303 B-cancer
- 100 101 1303 1304 I-cancer
melanomatous 101 113 1304 1316 I-cancer
skin 114 118 1317 1321 I-cancer
cancer 119 125 1322 1328 I-cancer
, 125 126 1328 1329 O
superficial 127 138 1330 1341 B-cancer
bladder 139 146 1342 1349 I-cancer
or 147 149 1350 1352 O
cervical 150 158 1353 1361 B-cancer
cancer 159 165 1362 1368 I-cancer
, 165 166 1368 1369 O
and 167 170 1370 1373 O
early 171 176 1374 1379 O
- 176 177 1379 1380 O
stage 177 182 1380 1385 O
prostate 183 191 1386 1394 B-cancer
cancer 192 198 1395 1401 I-cancer

Patients 0 8 1402 1410 O
with 9 13 1411 1415 O
distant 14 21 1416 1423 O
metastatic 22 32 1424 1434 B-cancer
disease 33 40 1435 1442 I-cancer
or 41 43 1443 1445 O
otherwise 44 53 1446 1455 O
not 54 57 1456 1459 O
confined 58 66 1460 1468 O
to 67 69 1469 1471 O
the 70 73 1472 1475 O
ipsilateral 74 85 1476 1487 O
hemithorax 86 96 1488 1498 O

Patients 0 8 1499 1507 O
with 9 13 1508 1512 O
porphyria 14 23 1513 1522 B-chronic_disease
or 24 26 1523 1525 O
hypersensitivity 27 43 1526 1542 O
to 44 46 1543 1545 O
porphyrin 47 56 1546 1555 B-allergy_name
or 57 59 1556 1558 O
porphyrin 60 69 1559 1568 B-allergy_name
- 69 70 1568 1569 I-allergy_name
like 70 74 1569 1573 I-allergy_name
compounds 75 84 1574 1583 I-allergy_name

Pregnant 0 8 1584 1592 B-pregnancy

Serum 0 5 1593 1598 B-clinical_variable
creatinine 6 16 1599 1609 I-clinical_variable
equal 17 22 1610 1615 O
or 23 25 1616 1618 O
greater 26 33 1619 1626 O
than 34 38 1627 1631 O
2.5 39 42 1632 1635 B-lower_bound
mg 43 45 1636 1638 I-lower_bound
/ 45 46 1638 1639 I-lower_bound
deciliter 46 55 1639 1648 I-lower_bound

Subjects 0 8 1649 1657 O
treated 9 16 1658 1665 O
with 17 21 1666 1670 O
pemetrexed 22 32 1671 1681 B-treatment
previously 33 43 1682 1692 O
will 44 48 1693 1697 O
be 49 51 1698 1700 O
eligible 52 60 1701 1709 O
only 61 65 1710 1714 O
if 66 68 1715 1717 O
30 69 71 1718 1720 B-upper_bound
days 72 76 1721 1725 I-upper_bound
have 77 81 1726 1730 O
elapsed 82 89 1731 1738 O
between 90 97 1739 1746 O
the 98 101 1747 1750 O
last 102 106 1751 1755 O
dose 107 111 1756 1760 O
of 112 114 1761 1763 O
pemetrexed 115 125 1764 1774 O
and 126 129 1775 1778 O
the 130 133 1779 1782 O
date 134 138 1783 1787 O
of 139 141 1788 1790 O
surgery 142 149 1791 1798 B-treatment

Subjects 0 8 1799 1807 O
who 9 12 1808 1811 O
have 13 17 1812 1816 O
received 18 26 1817 1825 O
more 27 31 1826 1830 O
than 32 36 1831 1835 O
2 37 38 1836 1837 B-lower_bound
doses 39 44 1838 1843 I-lower_bound
of 45 47 1844 1846 O
neo 48 51 1847 1850 O
- 51 52 1850 1851 O
adjuvant 52 60 1851 1859 O
chemotherapy 61 73 1860 1872 B-treatment

